INIS
cancer
100%
clinical trials
66%
interventions
66%
oncogenes
33%
doses
33%
cell proliferation
33%
design
33%
apoptosis
33%
correlations
33%
safety
33%
growth factors
33%
carcinogenesis
33%
molecules
33%
Medicine and Dentistry
Development
100%
Malignant Neoplasm
66%
Growth Factor
33%
Clinical Endpoint
33%
Programmed Cell Death
33%
Biological Product
33%
Cancer Prevention
33%
Cell Proliferation
33%
Carcinogenesis
33%
Immune Response
33%
Oncogene
33%
Introspection
33%
Marker
33%
Biochemistry, Genetics and Molecular Biology
Development
100%
Electric Potential
66%
Apoptosis
33%
Immune Response
33%
Carcinogenesis
33%
Cell Proliferation
33%
Introspection
33%
Dose
33%
Molecule
33%
Oncogene
33%